awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26851705-AF6C4EFF-C3A9-417A-882F-A6A077A14CFF
Q26851705-AF6C4EFF-C3A9-417A-882F-A6A077A14CFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851705-AF6C4EFF-C3A9-417A-882F-A6A077A14CFF
Therapeutic regulation of complement in patients with renal disease - where is the promise?
P2860
Q26851705-AF6C4EFF-C3A9-417A-882F-A6A077A14CFF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851705-AF6C4EFF-C3A9-417A-882F-A6A077A14CFF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
211977c4bb9127bd79dde661651de67bc17ffec8
P2860
A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia/reperfusion injury.